Huadong Medicine Co Ltd (000963) - Total Assets
Based on the latest financial reports, Huadong Medicine Co Ltd (000963) holds total assets worth CN¥39.93 Billion CNY (≈ $5.84 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Huadong Medicine Co Ltd (000963) shareholders funds for net asset value and shareholders' equity analysis.
Huadong Medicine Co Ltd - Total Assets Trend (1997–2024)
This chart illustrates how Huadong Medicine Co Ltd's total assets have evolved over time, based on quarterly financial data.
Huadong Medicine Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Huadong Medicine Co Ltd's total assets of CN¥39.93 Billion consist of 55.6% current assets and 44.4% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 13.9% |
| Accounts Receivable | CN¥10.52 Billion | 27.8% |
| Inventory | CN¥4.78 Billion | 12.6% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥4.68 Billion | 12.4% |
| Goodwill | CN¥2.91 Billion | 7.7% |
Asset Composition Trend (1997–2024)
This chart illustrates how Huadong Medicine Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Huadong Medicine Co Ltd.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Huadong Medicine Co Ltd's current assets represent 55.6% of total assets in 2024, a decrease from 74.3% in 1997.
- Cash Position: Cash and equivalents constituted 13.9% of total assets in 2024, up from 9.2% in 1997.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 19.0% of total assets, an increase from 0.0% in 1997.
- Asset Diversification: The largest asset category is accounts receivable at 27.8% of total assets.
Huadong Medicine Co Ltd Competitors by Total Assets
Key competitors of Huadong Medicine Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
|
USA | $5.76 Million |
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥31.46 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Tonghua Dongbao Pharmaceutical Co Ltd
SHG:600867
|
China | CN¥8.15 Billion |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
|
China | CN¥19.57 Billion |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
|
China | CN¥5.17 Billion |
|
Guobang Pharma Ltd
SHG:605507
|
China | CN¥10.58 Billion |
Huadong Medicine Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.56 | 1.48 | 1.70 |
| Quick Ratio | 1.20 | 1.14 | 1.23 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥8.14 Billion | CN¥6.92 Billion | CN¥6.02 Billion |
Huadong Medicine Co Ltd - Advanced Valuation Insights
This section examines the relationship between Huadong Medicine Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.62 |
| Latest Market Cap to Assets Ratio | 0.23 |
| Asset Growth Rate (YoY) | 13.0% |
| Total Assets | CN¥37.88 Billion |
| Market Capitalization | $8.56 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Huadong Medicine Co Ltd's assets below their book value (0.23x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Huadong Medicine Co Ltd's assets grew by 13.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Huadong Medicine Co Ltd (1997–2024)
The table below shows the annual total assets of Huadong Medicine Co Ltd from 1997 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥37.88 Billion ≈ $5.54 Billion |
+13.04% |
| 2023-12-31 | CN¥33.51 Billion ≈ $4.90 Billion |
+7.43% |
| 2022-12-31 | CN¥31.19 Billion ≈ $4.56 Billion |
+15.54% |
| 2021-12-31 | CN¥27.00 Billion ≈ $3.95 Billion |
+11.55% |
| 2020-12-31 | CN¥24.20 Billion ≈ $3.54 Billion |
+12.75% |
| 2019-12-31 | CN¥21.46 Billion ≈ $3.14 Billion |
+11.69% |
| 2018-12-31 | CN¥19.22 Billion ≈ $2.81 Billion |
+20.21% |
| 2017-12-31 | CN¥15.99 Billion ≈ $2.34 Billion |
+10.59% |
| 2016-12-31 | CN¥14.46 Billion ≈ $2.12 Billion |
+26.62% |
| 2015-12-31 | CN¥11.42 Billion ≈ $1.67 Billion |
+26.76% |
| 2014-12-31 | CN¥9.01 Billion ≈ $1.32 Billion |
+17.38% |
| 2013-12-31 | CN¥7.67 Billion ≈ $1.12 Billion |
+17.35% |
| 2012-12-31 | CN¥6.54 Billion ≈ $956.82 Million |
+11.89% |
| 2011-12-31 | CN¥5.84 Billion ≈ $855.12 Million |
+37.32% |
| 2010-12-31 | CN¥4.26 Billion ≈ $622.73 Million |
+19.26% |
| 2009-12-31 | CN¥3.57 Billion ≈ $522.18 Million |
+15.40% |
| 2008-12-31 | CN¥3.09 Billion ≈ $452.52 Million |
+23.59% |
| 2007-12-31 | CN¥2.50 Billion ≈ $366.14 Million |
+7.60% |
| 2006-12-31 | CN¥2.33 Billion ≈ $340.28 Million |
+13.22% |
| 2005-12-31 | CN¥2.05 Billion ≈ $300.54 Million |
+16.14% |
| 2004-12-31 | CN¥1.77 Billion ≈ $258.79 Million |
+23.24% |
| 2003-12-31 | CN¥1.43 Billion ≈ $209.98 Million |
+4.67% |
| 2002-12-31 | CN¥1.37 Billion ≈ $200.61 Million |
+10.45% |
| 2001-12-31 | CN¥1.24 Billion ≈ $181.63 Million |
+8.55% |
| 2000-12-31 | CN¥1.14 Billion ≈ $167.32 Million |
+13.79% |
| 1999-12-31 | CN¥1.00 Billion ≈ $147.04 Million |
+45.40% |
| 1998-12-31 | CN¥691.10 Million ≈ $101.13 Million |
+10.01% |
| 1997-12-31 | CN¥628.23 Million ≈ $91.93 Million |
-- |
About Huadong Medicine Co Ltd
Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. It operates through Pharmaceutical Industry, Pharmaceutical Business, Aesthetic Medicine, and Industrial Microbiology segments. The company distributes Chinese and western medicines, Chinese herbal medicines, and medical instruments; and immunosup… Read more